SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-013167
Filing Date
2019-04-26
Accepted
2019-04-25 19:49:59
Documents
5
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A stro-defa14a_20181231.htm DEFA14A 32203
2 GRAPHIC g0wsl5bvb4fs000004.jpg GRAPHIC 28488
3 GRAPHIC g0wsl5bvb4fs000003.jpg GRAPHIC 34246
4 GRAPHIC g0wsl5bvb4fs000001.jpg GRAPHIC 63006
5 GRAPHIC g0wsl5bvb4fs000002.jpg GRAPHIC 81763
  Complete submission text file 0001564590-19-013167.txt   319600
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38662 | Film No.: 19768943
SIC: 2836 Biological Products, (No Diagnostic Substances)